Tscan Therapeutics Inc (TCRX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Tscan Therapeutics Inc   (NASDAQ: TCRX)

Tscan Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TCRX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 71.11 % 65.43 % 47.43 %
Gross Margin (Q2 TTM) 85.22 % 79.56 % 66.39 % 46.67 %
Gross Profit Margin 5 Yr. Avg. - 70.97 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) 66.51 % 20.59 % 19.59 % 21.4 %
EBITDA Margin (Q2 TTM) -1225.81 % 27.11 % 20.86 % 19.31 %
EBITDA Margin 5 Yr. Avg. --1457.54 % 22.75 % 31.56 % 22.45 %
Operating Margin (Q2 MRQ) -2901.33 % 11.28 % 16.57 % 16.73 %
Operating Margin (Q2 TTM) -1695.15 % 16.53 % 17.92 % 16.52 %
Operating Margin 5 Yr. Avg. --1503.81 % 6.03 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 7.4 % 10.93 % 14.14 %
Pre-Tax Profit Margin (Q2 TTM) -1228.42 % 15.08 % 12.86 % 13.13 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) -2888.58 % 2.64 % 8.14 % 11.6 %
Net Margin (Q2 TTM) -1655.35 % 11.11 % 9.99 % 10.8 %
Net Margin 5 Yr. Avg. - 6.58 % 6.08 % 9.9 %



Business Segment Profit Margin
 
Reportable Segment
  Explore Reportable Segment Segment  -